Literature DB >> 6206464

Calcium metabolism and cystic fibrosis: mitochondrial abnormalities suggest a modification of the mitochondrial membrane.

A A von Ruecker, R Bertele, H K Harms.   

Abstract

A disorder of calcium (Ca2+) metabolism may be central to the pathogenesis of cystic fibrosis (CF). Average cellular Ca2+ levels in fibroblasts derived from patients with CF (ages, 14-25 yr; n = 25) were 36-77% higher than in matched controls depending on age of cell culture (9.0-10.6 versus 5.1-7.8 nmol/mg cellular protein). Cellular Ca2+ was significantly elevated in CF, but was not a reliable criterion for identifying CF cells because of the high variability of results. Studies of Ca2+ fluxes in cell organelles showed that mitochondria isolated from CF fibroblasts accumulate 2-3 times more Ca2+ than controls [79.5 +/- 8.2 versus 33.7 +/- 4.7 nmols X mg mitochondrial protein-1 X 10 min-1 (+/- SD)], Ca2+ accumulation in mitochondrial reliably distinguished between CF and control or heterozygote cells (P less than 0.0005, n = 11). In vitro experiments showed that Ca2+ influx and efflux are increased in isolated CF mitochondria, resulting in net Ca2+ accumulation. Ca2+ uptake in mitochondria is energy-dependent; some inhibitors of mitochondrial energy metabolism (atractyloside, oligomycin) influenced Ca2+ intake significantly more in CF than in control mitochondria. Furthermore, the average activities of NADH oxidase, NADH- and succinate-cytochrome c reductase were 77, 58, and 48% higher in CF mitochondria, respectively. This indicates that many functions associated with energy metabolism and the mitochondrial membrane (electron transport, ATP transport, and ATP hydrolysis) are not operating properly in CF, thus possibly causing the derangement of Ca2+ metabolism found in CF mitochondria and cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206464     DOI: 10.1203/00006450-198407000-00005

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  9 in total

1.  Pulmonary oxidative stress response in young children with cystic fibrosis.

Authors:  J Hull; P Vervaart; K Grimwood; P Phelan
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

Review 2.  Role of free radicals in the pathogenesis of cystic fibrosis.

Authors:  R K Brown; F J Kelly
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

3.  Increased carbon monoxide in exhaled air of patients with cystic fibrosis.

Authors:  P Paredi; P L Shah; P Montuschi; P Sullivan; M E Hodson; S A Kharitonov; P J Barnes
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

4.  Mitochondrial oxidative stress in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice.

Authors:  Leonard W Velsor; Chirag Kariya; Remy Kachadourian; Brian J Day
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-08       Impact factor: 6.914

5.  Characterization of mitochondrial function in cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function.

Authors:  Anna Atlante; Maria Favia; Antonella Bobba; Lorenzo Guerra; Valeria Casavola; Stephan Joel Reshkin
Journal:  J Bioenerg Biomembr       Date:  2016-05-05       Impact factor: 2.945

Review 6.  CFTR activity and mitochondrial function.

Authors:  Angel Gabriel Valdivieso; Tomás A Santa-Coloma
Journal:  Redox Biol       Date:  2013-02-05       Impact factor: 11.799

7.  CNS imaging studies in cystic fibrosis patients presenting with sudden neurological events.

Authors:  Samantha Ellis; Catherine Rang; Tom Kotsimbos; Dominic Keating; Felicity Finlayson; Richard Stark; Dominic Thyagarajan; John Wilson
Journal:  BMJ Open Respir Res       Date:  2019-08-09

Review 8.  Mechanisms of the noxious inflammatory cycle in cystic fibrosis.

Authors:  Mathilde Rottner; Jean-Marie Freyssinet; M Carmen Martínez
Journal:  Respir Res       Date:  2009-03-13

9.  A Pseudomonas aeruginosa EF-hand protein, EfhP (PA4107), modulates stress responses and virulence at high calcium concentration.

Authors:  Svetlana A Sarkisova; Shalaka R Lotlikar; Manita Guragain; Ryan Kubat; John Cloud; Michael J Franklin; Marianna A Patrauchan
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.